title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study",20220802T122759,https://www.benzinga.com/general/biotech/22/08/28308082/biotech-daily-trial-setback-for-eliem-therapeutics-allarity-drops-work-on-cancer-monotherapies-ax,SRPT,0.105372,Neutral,0.0
"Gene Therapy Market Set for 19% CAGR Surge, Reaching USD 38.34 Billion by 2031 | SkyQuest Technology",20240912T133000,https://www.benzinga.com/pressreleases/24/09/g40833623/gene-therapy-market-set-for-19-cagr-surge-reaching-usd-38-34-billion-by-2031-skyquest-technology,SRPT,0.039878,Neutral,0.026899
Aquestive  ( AQST )  to Report Q4 Earnings: Here's What to Expect,20240221T152700,https://www.zacks.com/stock/news/2229443/aquestive-aqst-to-report-q4-earnings-heres-what-to-expect,SRPT,0.277118,Neutral,0.068177
Allogene  ( ALLO )  Down 20% on Strategic Changes in Pipeline,20240105T175200,https://www.zacks.com/stock/news/2206512/allogene-allo-down-20-on-strategic-changes-in-pipeline,SRPT,0.091509,Neutral,0.047721
Esperion  ( ESPR )  Settles Milestone Dispute With Daiichi Sankyo,20240104T160800,https://www.zacks.com/stock/news/2205756/esperion-espr-settles-milestone-dispute-with-daiichi-sankyo,SRPT,0.120431,Neutral,0.053112
Neuromuscular Disease Therapeutics Market size to grow by USD 65.13 billion from 2022-2027| Aquestive ... - PR Newswire,20231201T183000,https://www.prnewswire.com/news-releases/neuromuscular-disease-therapeutics-market-size-to-grow-by-usd-65-13-billion-from-2022-2027-aquestive-therapeutics-inc-bausch-health-companies-inc-biogen-inc-and-more-among-the-major-companies-in-the-market--technavio-302002042.html,SRPT,0.059636,Neutral,0.014995
Biotech ETFs to Watch,20240311T211500,https://investingnews.com/daily/life-science-investing/biotech-investing/small-biotech-etfs/,SRPT,0.075635,Neutral,0.053488
Sarepta Therapeutics  ( SRPT )  Q2 2022 Earnings Call Transcript,20220803T033047,https://www.fool.com/earnings/call-transcripts/2022/08/02/sarepta-therapeutics-srpt-q2-2022-earnings-call-tr/,SRPT,0.007084,Somewhat-Bullish,0.165527
"Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives",20240717T120000,https://www.globenewswire.com/news-release/2024/07/17/2914481/8339/en/Cassava-Sciences-Announces-Changes-in-Executive-Leadership-Enhanced-Corporate-Governance-and-Other-Initiatives.html,SRPT,0.081276,Neutral,0.0
Alkermes Issues Letter to Shareholders Highlighting Skills and Experience of Refreshed Board of Directors - Alkermes  ( NASDAQ:ALKS ) ,20230613T110000,https://www.benzinga.com/pressreleases/23/06/n32831446/alkermes-issues-letter-to-shareholders-highlighting-skills-and-experience-of-refreshed-board-of-di,SRPT,0.019102,Neutral,0.0
"Stocks making the biggest moves midday: Lowe's, 3M, First Horizon, Nio and more",20230301T181040,https://www.cnbc.com/2023/03/01/stocks-moving-big-midday-low-mmm-fhn-nio.html,SRPT,0.114137,Neutral,0.013645
"Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket - AMC Entertainment  ( NYSE:AMC ) , Bilibili  ( NASDAQ:BILI ) ",20230301T125522,https://www.benzinga.com/news/23/03/31120644/why-reata-pharmaceuticals-shares-are-trading-higher-by-140-here-are-20-stocks-moving-premarket,SRPT,0.150122,Somewhat-Bullish,0.268336
"First Republic Bank, Blend Labs, Purple Innovation And Other Big Stocks Moving Lower On Friday - Aspen Aerogels  ( NYSE:ASPN ) , Blend Labs  ( NYSE:BLND ) ",20230317T155529,https://www.benzinga.com/news/23/03/31400166/first-republic-bank-blend-labs-purple-innovation-and-other-big-stocks-moving-lower-on-friday,SRPT,0.219809,Neutral,0.0
SRPT Finishes Enrolment in Late-Stage Study for Rare Muscular Disorder,20241219T134500,https://www.zacks.com/stock/news/2385698/srpt-finishes-enrolment-in-late-stage-study-for-rare-muscular-disorder,SRPT,0.342487,Neutral,-0.026563
Vanda  ( VNDA )  to Report Q1 Earnings: What's in the Cards?,20240424T175800,https://www.zacks.com/stock/news/2261585/vanda-vnda-to-report-q1-earnings-whats-in-the-cards,SRPT,0.1437,Somewhat-Bullish,0.171113
GSK Gears Up for Q1 Earnings: Here's What to Expect,20240423T171600,https://www.zacks.com/stock/news/2260559/gsk-gears-up-for-q1-earnings-heres-what-to-expect,SRPT,0.145437,Somewhat-Bullish,0.164755
Incyte  ( INCY )  to Report Q1 Earnings: What's in the Cards?,20240423T134400,https://www.zacks.com/stock/news/2260352/incyte-incy-to-report-q1-earnings-whats-in-the-cards,SRPT,0.139804,Neutral,0.085178
AbbVie  ( ABBV )  to Report Q1 Earnings: What's in the Cards?,20240422T165600,https://www.zacks.com/stock/news/2259539/abbvie-abbv-to-report-q1-earnings-whats-in-the-cards,SRPT,0.149656,Somewhat-Bullish,0.175155
Viking  ( VKTX )  to Report Q1 Earnings: What's in the Cards?,20240419T151600,https://www.zacks.com/stock/news/2258702/viking-vktx-to-report-q1-earnings-whats-in-the-cards,SRPT,0.152499,Somewhat-Bullish,0.180994
CytomX  ( CTMX )  to Report Q4 Earnings: Here's What to Expect,20240227T165200,https://www.zacks.com/stock/news/2232603/cytomx-ctmx-to-report-q4-earnings-heres-what-to-expect,SRPT,0.355588,Neutral,0.070899
Jasper Therapeutics  ( JSPR )  Surges 110% in a Month: Here's Why,20240124T171400,https://www.zacks.com/stock/news/2215186/jasper-therapeutics-jspr-surges-110-in-a-month-heres-why,SRPT,0.101154,Neutral,0.043569
AstraZeneca's  ( AZN )  Imfinzi Combo Meets Liver Cancer Study Goal,20240122T194200,https://www.zacks.com/stock/news/2213719/astrazenecas-azn-imfinzi-combo-meets-liver-cancer-study-goal,SRPT,0.09495,Neutral,0.040773
Edgewise  ( EWTX )  Rallies 35% on Issue of New Common Stock,20240122T190600,https://www.zacks.com/stock/news/2213712/edgewise-ewtx-rallies-35-on-issue-of-new-common-stock,SRPT,0.107736,Neutral,0.042241
TransCode  ( RNAZ )  Down 50% on Issue of New Common Stock,20240119T180900,https://www.zacks.com/stock/news/2213010/transcode-rnaz-down-50-on-issue-of-new-common-stock,SRPT,0.11894,Neutral,0.043817
ADC Therapeutics  ( ADCT )  Rises 43% in a Month: Here's Why,20240119T180500,https://www.zacks.com/stock/news/2213007/adc-therapeutics-adct-rises-43-in-a-month-heres-why,SRPT,0.102888,Neutral,0.043781
Allakos  ( ALLK )  Plummets 60% on Ending Development of Lead Drug,20240117T171000,https://www.zacks.com/stock/news/2211650/allakos-allk-plummets-60-on-ending-development-of-lead-drug,SRPT,0.120733,Neutral,0.04636
Adaptimmune  ( ADAP )  Surges More Than 80% in a Month: Here's Why,20240116T161700,https://www.zacks.com/stock/news/2210881/adaptimmune-adap-surges-more-than-80-in-a-month-heres-why,SRPT,0.119532,Neutral,0.043907
Iovance  ( IOVA )  Surges More Than 150% in 3 Months: Here's Why,20240115T172700,https://www.zacks.com/stock/news/2210369/iovance-iova-surges-more-than-150-in-3-months-heres-why,SRPT,0.085629,Neutral,0.042008
Emergent  ( EBS )  Gets $235.8M DoD Contract for Anthrax Vaccine,20240112T192000,https://www.zacks.com/stock/news/2209718/emergent-ebs-gets-2358m-dod-contract-for-anthrax-vaccine,SRPT,0.113866,Neutral,0.045288
Aclaris  ( ACRS )  Down 21% on Mixed Results From Eczema Study,20240111T164600,https://www.zacks.com/stock/news/2209029/aclaris-acrs-down-21-on-mixed-results-from-eczema-study,SRPT,0.096866,Neutral,0.043075
Why Sarepta's  ( SRPT )  Stock Price Moved Up 17% on Tuesday,20240110T174900,https://www.zacks.com/stock/news/2208461/why-sareptas-srpt-stock-price-moved-up-17-on-tuesday,SRPT,0.172097,Neutral,0.127509
Why Moderna  ( MRNA )  Stock Price Was Up 13% on Tuesday,20240103T185600,https://www.zacks.com/stock/news/2205244/why-moderna-mrna-stock-price-was-up-13-on-tuesday,SRPT,0.089797,Neutral,0.052721
Can Rigel Pharmaceuticals  ( RIGL )  Beat Q4 Earnings Estimates?,20240219T133400,https://www.zacks.com/stock/news/2227756/can-rigel-pharmaceuticals-rigl-beat-q4-earnings-estimates,SRPT,0.274012,Neutral,0.067553
"Earnings Scheduled For May 4, 2022",20220504T083630,https://www.benzinga.com/news/earnings/22/05/26983503/earnings-scheduled-for-may-4-2022,SRPT,0.010898,Somewhat-Bearish,-0.332341
"Canopy Growth, Avadel Pharmaceuticals And Other Big Stocks Moving Lower On Friday - Avadel Pharmaceuticals  ( NASDAQ:AVDL ) , C3.ai  ( NYSE:AI ) ",20230623T143343,https://www.benzinga.com/news/23/06/32985326/canopy-growth-avadel-pharmaceuticals-and-other-big-stocks-moving-lower-on-friday,SRPT,0.561184,Bullish,0.410828
